Tempus Al TEM 深 滬
等待開盤 06-25 09:30:00 美东时间
51.94
+3.330
+6.85%
華盛通- 最 高52.56
- 今 開48.615
- 成交量 686.83万股
- 最 低 48.45
- 昨 收 48.61
- 總市值 93.27亿
- 52周最高 104.32
- 市盈率 靜 --
- 換手率 3.82%
- 52周最低 41.73
- 委 比 -68.07%
- 總股本 1.80亿
- 歷史最高 104.32
- 量 比 1.17
- 振 幅 8.46%
- 歷史最低 22.89
- 每 手 1
- 風險率 14.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ambry Study Shows RNA Testing May Clarify Uncertain Genetic Results
Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ:TEM), announced peer-reviewed research demonstrating the potential for variant-specific RNA testing to
06-09 18:07
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed at accelerating drug research.
06-05 19:01
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Tempus AI shares are trading higher. The company announced expansion of new indications to its AI-enabled Next platform ahead of the 2026 ASCO Annual Meeting.
Tempus AI shares are trading higher. The company announced expansion of new ind...
05-29 01:55
Why Is Tempus AI Stock Surging On Thursday?
Discover why Tempus AI Inc (NASDAQ:TEM) stock is surging today following major platform expansions and landmark clinical data ahead of ASCO 2026.
05-29 01:47
美股异动 | 软件股集体上扬！Snowflake涨近36%，Palantir涨超4%；微软涨超3%，将于下周发布新的编码模型
软件股集体上扬！Snowflake涨近36%，Palantir涨超4%；量子计算概念普涨，IBM涨超4%；微软涨超3%，将于下周发布新的编码模型>>
05-28 22:09
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
Bristol Myers Squibb expands AI efforts through Anthropic and Tempus partnerships as shares edge higher Wednesday.
05-21 01:09
Tempus AI Partners With Bristol Myers Squibb Over Leveraging AI, Multimodal Real-World Data, Data Science Techniques For Clinical Trial Designs
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new initiative with Bristol Myers Squibb (NYSE: BMY). This collaboration aims to leverage AI,
05-14 20:40
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
